Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1Phase 1 1

Status

Unknown 15Completed 5Recruiting 4Not yet recruiting 3Terminated 2

Sponsor Class

OTHER 3UNKNOWN 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Stomach Neoplasms 3Carcinoma, Hepatocellular 1Advanced Pancreatic Cancer 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × gimeracil × Clear all
NCT03175679 2024-09-19

Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC

Beijing YouAn Hospital

Phase 1 Completed
10 enrolled 14 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT01515748 2023-12-13

PRODIGY

Sanofi

Phase 3 Completed
530 enrolled 11 charts
Gastrointestinal

Stomach Neoplasms

NCT03415802 2021-02-01

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

ChineseAMS

Phase 2 Completed
32 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

NCT01516944 2020-02-13

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Hebei Medical University

Phase 2/3 Completed
749 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02527785 2017-08-23

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

Hallym University Medical Center

Phase 2 Completed
44 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡